Efficacy of pembrolizumab in patients with advanced mucosal melanoma enrolled in the KEYNOTE-001, 002, and 006 studies. (February 2017) - Butler, M.; Hamid, O.; Ribas, A.; Hodi, F.S.; Walpole, E.; Dauad, A.; Arance, A.; Brown, E.; Hoeller, C.; Mortier, L.; Schachter, J.; Long, J.; et al.